Seminal
The magazine and atlas of EU-funded researchA new publication from the web and AI team at Scott Charnley

Atlas / Germany

European Research Council grant · Running

NEUROCAST Neurodevelopmental forecasting of mental illness in adolescence

Coordinator
Forschungszentrum Julich GmbH, Germany
Runs
1 February 2027 to 31 January 2032
Status
Running
EU funding
€1.5m
Total cost
€1.5m
Partners
1 organisations in 1 countries
Type
European Research Council grant
Grant agreement
101301486

What the project is doing

In the project's own words, from its summary on CORDIS.

Adolescence is a period of profound biological and social changes that drive a transition towards independence. Yet, paradoxically, these evolutionarily adaptative processes spark a rise in mental illness. Why most psychiatric disorders emerge in adolescence, and what differentiates vulnerability from resilience, remains unclear. This uncertainty hampers efforts to advance adolescent psychiatry in an era of declining mental health.

NEUROCAST addresses this challenge by shifting focus in developmental neuroscience from population averages to the rich diversity of individual trajectories. Capitalising on recently released large-scale datasets (n>10,000) of longitudinal magnetic resonance imaging in adolescents, NEUROCAST will produce a multi-dimensional reference frame that captures distinctive spatiotemporal modes of neurodevelopment. This framework, built upon innovative multi-modal neuroimaging, will provide a unifying account of how internal and external forces interactively shape individual-specific patterns of brain maturation, allowing us to ascertain why certain trajectories lead to psychopathology.

A critical barrier to translating these insights into clinical practice is the reliance on multi-year follow-ups to reveal developmental trajectories. NEUROCAST will overcome this hurdle by creating a first-of-its-kind neurodevelopmental forecasting tool, which approximates one’s trajectory from a single timepoint. This approach will enable analysis of clinical studies and evaluate whether neurodevelopmental forecasts are more effective than traditional diagnostic methods in predicting clinical outcomes, such as symptom progression and treatment response.

Bridging large-scale discovery with clinical translation, NEUROCAST harnesses neuroimaging and machine learning to advance a new paradigm in developmental science and adolescent psychiatry, one in which mental illnesses are redefined by their neurodevelopmental origins.

Who is involved

OrganisationCityCountryRole
Forschungszentrum Julich GmbHJulichGermanyCoordinator

Source: CORDIS, European Commission. Data of 5 Nov 2026, reused under the Commission's reuse policy. View on CORDIS · Grant DOI